Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MLAB vs ELSE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLAB Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–6 Matrix Metrics)

MLAB Overall Winner 6-Pillar Tally: MLAB 3 – 2 ELSE (1 Tie) Matrix Metrics: MLAB 4 – 6 ELSE

As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MLAB carries a Unified Composite Score of 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin), whereas ELSE carries 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin).

  • Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. MLAB 55.4/100 HOLD), MLAB captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. -8.5% operating margin) and revenue trajectory (+2.6% vs. +15.2% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MLAB vs ELSE
MLAB NASDAQ Head-to-Head Winner
Mesa Laboratories Inc
Industrial Instruments For Measurement, Display, And Control
$127.93
-4.11% 1D
Market Cap $749.8M
TTM Revenue $251M
Forward P/E 23.7x
Beta / 30D Vol 1.13β · 55% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 48.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.8 · SMA20: $130.92 · SMA50: $130.04
ELSE NASDAQ
Electro-Sensors Inc
Industrial Instruments For Measurement, Display, And Control
$7.74
+0.0% 1D
Market Cap $27.3M
TTM Revenue $10M
Forward P/E 14.7x
Beta / 30D Vol 0.28β · 2% Vol
Unified Composite Score
57.3 / 100 HOLD
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 68
RSI-14: 68.4 · SMA20: $7.71 · SMA50: $7.69

6-Pillar Scorecard Institutional Category Breakdown (MLAB 3 – 2 ELSE)

Columns: Metric · MLAB · ELSE
1. Valuation Multiples ELSE
Forward P/E 23.7x 14.7x
Trailing P/E 115.0x 96.8x
PEG Ratio N/M 3.15x
EV / Revenue 3.0x 2.6x
2. Growth & Scale MLAB
Revenue Growth (YoY) +2.6% +15.2%
Earnings Growth (YoY) +67.0% -49.1%
TTM Revenue (USD) $251M $10M
Market Cap $749.8M $27.3M
3. Profitability & Quality MLAB
Gross Margin 64.8% 51.5%
Operating Margin 10.4% -8.5%
Net Profit Margin 2.6% 2.4%
Return on Equity (ROE) 3.6% 1.7%
4. Balance Sheet & Cash Flow MLAB
Cash Generation (TTM) $49M EBITDA $667,000
Cash Flow Margin 19.4% EBITDA Mgn 6.4%
Net Cash / Leverage $34.66 Book/Sh · 3.6% ROE $4.22 Book/Sh · 1.7% ROE
Dividend Yield 0.46% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ELSE
OpEx & R&D Intensity 54.4% of Rev ($137M) 60.0% of Rev ($6.3M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MLAB (4) vs ELSE (6)
Institutional Metric MLAB ELSE Criterion Row Edge
Market Capitalization
Scale
$749.8M $27.3M Larger Scale MLAB
Trailing P/E Ratio
Valuation
115.0x 96.8x Lower Multiple ELSE
Forward P/E Ratio
Valuation
23.7x 14.7x Lower Multiple ELSE
Revenue Growth (YoY)
Growth
+2.6% +15.2% Higher Growth ELSE
Operating Margin (TTM)
Profitability
10.4% -8.5% Higher Margin MLAB
Net Profit Margin
Profitability
2.6% 2.4% Higher Margin MLAB
Return on Equity (ROE)
Capital Efficiency
3.6% 1.7% Higher ROE MLAB
52-Week Range Position
Momentum
78% ($70–$144) 100% ($4–$8) Stronger Trend ELSE
Beta / 30D Volatility
Risk Regime
1.13β · 55% Vol 0.28β · 2% Vol Lower Realized Risk ELSE
Unified Institutional Score
Composite Signal
55.4 / 100 (HOLD) 57.3 / 100 (HOLD) Higher Composite ELSE
Trailing 12M Revenue (USD)
Operating Scale
$251M $10M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.8% 51.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.0x EV/Rev 3.15x PEG · 2.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$49M EBITDA ($34.66 Book/Sh · 3.6% ROE) $667,000 ($4.22 Book/Sh · 1.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MLAB +0.45 pp
MLAB: +1.5% · ELSE: +1.05%
3M Horizon MLAB +4.2 pp
MLAB: +5.51% · ELSE: +1.31%
6M Horizon ELSE +61.84 pp
MLAB: +14.94% · ELSE: +76.78%
1Y Horizon ELSE +25.03 pp
MLAB: +42.87% · ELSE: +67.9%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLAB vs ELSE. Trailing 12-month operating profitability (MLAB 10.4% vs ELSE -8.5%) and valuation multiples (MLAB 23.7x vs ELSE 14.7x Forward P/E) are benchmarked directly in Pillar 4 below.

MLAB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$251M
Gross Margin64.8%
Op. Margin10.4%
ROE / Fwd P/E3.6% · 23.7x
ELSE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$10M
Gross Margin51.5%
Op. Margin-8.5%
ROE / Fwd P/E1.7% · 14.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MLAB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ELSE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ELSE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MLAB Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $749.8M market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 54.4% of Rev ($137M)
90D Engineering Disclosures 0 Published
ELSE Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $27.3M market capitalization and -8.5% operating margin.
OpEx & R&D Reinvestment 60.0% of Rev ($6.3M)
90D Engineering Disclosures 0 Published

Investor FAQ MLAB vs ELSE Key Questions & Quantitative Answers

As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MLAB carries a Unified Composite Score of 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin), whereas ELSE carries 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin). Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. MLAB 55.4/100 HOLD), MLAB captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (10.4% vs. -8.5% operating margin) and revenue trajectory (+2.6% vs. +15.2% YoY).

MLAB leads the Growth & Scale pillar: MLAB posts +2.6% YoY revenue growth and +67.0% YoY earnings growth on $251M TTM revenue (64.8% gross margin, 10.4% operating margin), compared with ELSE at +15.2% YoY revenue growth and -49.1% YoY earnings growth on $10M TTM revenue (51.5% gross margin, -8.5% operating margin). On trailing 12-month operating scale, MLAB generates $251M in USD-normalized revenue versus $10M for ELSE. In operating R&D and SG&A reinvestment, MLAB deploys 54.4% of Rev ($137M) (0 90-day corporate R&D disclosures) versus 60.0% of Rev ($6.3M) (0 disclosures) for ELSE.

ELSE screens cheaper on headline valuation multiples. MLAB trades at 23.7x Forward P/E, 115.0x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (19.4% EBITDA margin), whereas ELSE trades at 14.7x Forward P/E, 96.8x Trailing P/E, 3.15x PEG, and 2.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MLAB (3.6% ROE) versus ELSE (1.7% ROE) capital efficiency.

In options market volatility and institutional positioning, MLAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.13β · 55% Vol realized risk). By comparison, ELSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.